|Articles|October 2, 2020
High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
2
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
3
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5